GlassScriptPhysician profile
Michael J Norgard
NPI 1124127733
$7,350.33
in general payments reported to CMS, 2019-2025
12 companies · $6,995 in 2025
The $6,995 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.54 · 2020: $15.70 · 2022: $59.39 · 2023: $185 · 2024: $82.62 · 2025: $6,995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $2,114 · Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $2,114.14 |
| Food and Beverage | $648.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,894.08 | 2025 | |
| Medtronic, INC. | $124.44 | 2023-2025 | Interstim, V-Loc 180 |
| Axonics, INC. | $82.12 | 2022-2024 | Axonics |
| Myriad Women'S Health, INC. | $56.95 | 2023 | Myrisk |
| Femselect INC. | $42.99 | 2024 | Enplace |
| E.R. Squibb & Sons, L.L.C. | $39.08 | 2020-2025 | Eliquis |
| Phathom Pharmaceuticals, INC. | $28.29 | 2025 | Voquezna |
| Pfizer INC. | $23.04 | 2022 | |
| Astellas Pharma US INC | $20.39 | 2023 | Veozah |
| Coopersurgical, INC. | $18.18 | 2023 | Endosee |
| Merck Sharp & Dohme LLC | $12.54 | 2019 | |
| Kerecis Limited | $8.23 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Norgard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.